DeviceTalks Podcast Network

As a thank you for subscribing and listening to the DeviceTalks Weekly Podcast we built a special code to help you register for the Oct. 18-19 DeviceTalks West conference at the Santa Clara Convention Center. Please give a listen! Go to DeviceTalks.com to register now!! Save $300 off the full registration price. Plus, we replay our keynote interview with Intuitive CEO Gary Guthart at last year’s DeviceTalks West event. In this conversation Guthart will provide additional details of Intuitive’s move into endoscopic robotics including the ION robot. He’ll give his assessment of the growing competition in surgical robotics and what it means for Intuitive. Finally, he shares why he thinks the term surgical robotics may have no meaning in the future.

A little over a year after taking over the CEO role at Ambu A/S, Britt Meelby Jensen visits the DeviceTalks Weekly Podcast to draw lessons from her career that led her to lead the single-use endoscope leader last year. At the time, Meelby Jensen says Ambu was missing Wall Street expectations. In this interview, Jensen highlights the benefits of single-use endoscopes, such as improved workflow and reduced waiting times, and emphasizes Ambu's focus on sustainability. She’ll also review the company’s plan to retain its position in the white-hot single-use scope industry. But first Host Tom Salemi take a dive into earnings week with MassDevice Executive Editor Chris Newmarker and Associate Editor Sean Whooley. We won’t dig too deep into the numbers, but instead we’ll ask why Wall Street investors don’t seem too impressed with the performance of some high-flying medical device companies.

Join us at DeviceTalks West on Oct. 18-19 for some in-person discussions!

Thanks for listening to the DeviceTalks Weekly Podcast.

Subscribe to the DeviceTalks Podcast Network on any major podcast application.

This special episode of Boston Scientific Talks brings you DeviceTalks Boston’s keynote conversation with Boston Scientific's executive leaders Meghan Scanlon, President of Urology; Jennifer Saunders, Sr. Manager of Medical Affairs; Ben Cutone, Global Franchise Director of Prostate Health; and Kristin LaRocca, Senior Vice President of Sales.

In the conversation, the key figures delve into the innovative strategies and technologies shaping the urology field, highlighting the LithoVue™ Elite Single-Use Digital Flexible Ureteroscope System. They explore how Boston Scientific is addressing care disparities in underrepresented communities, pioneering programs like "close the gap" in cardiology, and advancing accessibility and equality. The conversation also highlights the importance of data-driven decision-making, clinical evidence, and humble dialogue with clinicians to commercialize innovative strategies. The panelists discuss the challenges and rewards of disrupting the market, the role of health economics, and the unique contributions of urologists as innovators. They also touch on commercial modeling and the importance of empathy, self-awareness, and courage in bringing new ideas to life. Tune in to discover how Boston Scientific is not only advancing urological care but also the way the leadership team approaches problems and solutions.

Thank you to Clari for sponsoring this episode of Boston Scientific Talks. Go to Clari.com to learn about its unique revenue platform.

Thank you for listening to the Boston Scientific Podcast. Subscribe to this podcast on every major podcast platform.

This week's episode features the first of what's sure to be many audio appearances by DeviceTalks Managing Editor Kayleen Brown! We’re also visited by Lisa Carmel and Stephanie Jone, co-chairs of MedtechWomen’s MedtechVISION conference, which is taking place on Sept. 12. They share how the conference's important agenda took shape. Go to MedtechWomen.org to register.

Finally, we learn about an exciting new neuromodulation start-up called Motif Neurotech which is developing a tiny, implantable sensor that could advance how TMS therapy is delivered. Steve Goetz, a veteran of Medtronic’s neuromodulation business, explained why he left the giant to join this rising company as chief technology officer.

Thanks for listening to the DeviceTalks Weekly Podcast.

Subscribe to the DeviceTalks Podcast Network on any major podcast application!

In the newest episode of AbbottTalks, Allen Burton, Divisional VP and Chief Medical Officer of Neuromodulation at Abbott, shares insights into the company's innovative neuromodulation therapies.

Burton delves into Abbott's FDA-approved treatment for chronic back pain, which uses electrical stimulation to alleviate pain, improve functionality, and reduce reliance on opioids.

Burton discusses Abbott’s recent FDA approval to treat people who suffer from back pain with limited surgical options. He also expands on how the company's pioneering treatment for painful diabetic peripheral neuropathy, a condition affecting millions of Americans. This treatment uses electrical stimulation to dampen painful signals in the feet, enabling patients to regain mobility and control over their lives. Burton further introduces the Eterna SCS System, the smallest neurostimulation system in the market, which offers patients a low charging burden and indications for MRI compatibility.

Listen to the full episode to hear directly from Abbott's Neuromodulation CMO on how Abbott's patient-centric neuromodulation therapies are impacting the lives of patients suffering from chronic pain and diabetic peripheral neuropathy.

Thank you to Resonant Link for sponsoring this episode of AbbottTalks. For more information about Resonant Link go to www.Resonant-Link.com.

Thank you for listening to the AbbottTalks Podcast.

In this episode, Host Tom Salemi learns the Elixir Medical story from CEO Motasim Sirhan, who has spent most of his medtech career developing new vascular implants to prop open previously occluded blood vessels. Sirhan led developing of early version of bare metal stents while at Guidant. He’d go on to start and sell a company that developed another vascular device before pairing with Invus Group to start Elixir Medical in 2005. After a false start, the company is collecting promising clinical data for its DynamX vascular scaffolding system. We’ll learn why Sirhan sees this as an leap forward from drug-eluting stents. He also shares stories from his career about taking chances and overcoming fears. This episode is sponsored by DeviceTalks West.

Thanks for listening to the DeviceTalks Weekly Podcast.

You can subscribe to the DeviceTalks Podcast Network on any major podcast application.

In this rare origin-story episode of Boston Scientific Talks, Boston Scientific Founder John Abele unravels the company's unique journey from its inception to becoming a global leader in the medical device industry. Abele delves into the strategic financial planning and diversified product portfolio that shielded the company during challenging times. He underscores the power of partnerships and educational initiatives in making their groundbreaking technology accessible to physicians.

Abele also highlights the company's focus on implementing new ideas and the importance of understanding the evolving needs of the medical community. He shares how Boston Scientific's mission to reduce risks, trauma, cost, and time has improved patients' quality of life and empowered physicians with the tools to revolutionize their practices.

Tune in now to hear from one of medtech's pioneers and get a rare glimpse into Boston Scientific's hiring strategy, emphasizing the value of curiosity, understanding generational dynamics, and the delicate balance between competition and cooperation.

Thank you to Zeus for sponsoring this episode of Boston Scientific Talks. For more information about Zeus go to www.ZeusInc.com.

Thank you for listening to the Boston Scientific Podcast.

In this week’s episode, Anthony Fernando, President and CEO of Asensus Surgical, discusses the company's journey in the field of surgical robotics and its focus on digital surgery. He highlights the need for technology to improve outcomes, reduce costs, and increase productivity in the surgical space. Asensus offers the Senhance platform, a robotic system that incorporates machine vision and machine learning to assist surgeons. They are also developing Luna, an integrated digital surgery solution that aims to provide flexibility and collaboration in the operating room. Fernando shares his outlook on the future of surgical robotics. He also gives some advice for medical device executives who are pondering a position outside of the US. Editorial Director Tom Salemi also unpacks the agenda for DeviceTalks West, giving credit to listeners for helping him choose topic and speakers. Register for the conference at DeviceTalks.com.

In this episode of IntuitiveTalks, Glenn Vavoso, a U.S. Navy Veteran and SVP and General Manager APAC at Intuitive, begins by sharing how his time in the Navy led him on a winding road to medtech and, later, valuable insights into the company's strategic expansion in Asia's medical device market, including a $100 million investment.

Also, in the episode, Vavoso discusses the factors that led to Intuitive's transition from a distributor model to a direct selling model, highlighting the importance of being close to the customer and directly involved in the market. He also provides an overview of the attitude and adoption limitations towards surgical robotics in various Asian countries, focusing on Japan and Korea, and his strategy to overcome the obstacles. He further delves into the competitive landscape of surgical robotic systems in Asia, revealing that there are 11 active market-released competitive robotic systems in the region. Despite the competition, he emphasizes that there is more opportunity ahead than behind, especially in top-tier institutions.

Lastly, Vavoso also touches on the impact of COVID-19 on their operations, explaining how the pandemic has led to a shift in their approach to customer engagement and remote communication with surgeons and hospital executives.

Check out the episode to learn how by focusing on opportunities in China and South Korea, building local partnerships, and utilizing virtual tools, Vavoso has charted a course for Intuitive to increase its reach and impact throughout Asia.

Join us at DeviceTalk West this October 18-19 at the Santa Clara Convention Center. Visit West.DeviceTalks.com to see our lineup of speakers, panels, and sessions.

In this episode, Boston Scientific Chair, CEO and President Mike Mahoney discusses his journey in the medical device industry, the qualities that make a great leader, and the strategies that have fueled the company's growth.

Inspired by his grandfather, a cardiac surgeon, Mahoney initially wanted to become a doctor but ended up pursuing a career in business. Mahoney saw an opportunity at Boston Scientific when the company was struggling. Despite the risks involved, he took on the role of CEO because he believed in his skills and had a long-term vision for the company.

Through the efforts of the company's leaders, a strong supply chain team, efficient operations, and a robust innovation pipeline, Boston Scientific has managed to maintain a 14% growth rate in a challenging market environment.

Mahoney also highlights the company's focus on interventional medicine, which allows for quick procedures and same-day patient discharges, reducing the burden on hospitals. Mahoney further discusses the company's urology division, which has grown from a $500 million business to a $2 billion business. This growth has been fueled by a combination of organic R&D and acquisitions, creating a wide portfolio of differentiated products. Mahoney further elaborates on the company's diverse portfolio, mentioning the success of their peripheral vascular business and the potential of their diagnostics portfolio.

Tune in to this episode for more on Mahoney’s strategies, challenges, and opportunities, offering valuable insights into the company's approach to driving growth and innovation in the medical device industry.

Thank you to Resonant Link for sponsoring this episode of Boston Scientific Talks. For more information about Resonant Link go to www.Resonant-Link.com.

Thank you for listening to the Boston Scientific Talks Podcast.

Subscribe to this podcast on every major podcast platform.